All the news Showing 10 of 553 articles from: United StatesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Injecting drug use One in five new cases of hepatitis C in people who inject drugs due to unstable housing, modelling shows Keith Alcorn / 11 January 2022 Unstable housing may be responsible for up to one in five new infections with HIV or hepatitis C among people who inject drugs in the United Kingdom and the United States, a ... Hepatocellular carcinoma (HCC) Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Treatment for previous non-responders & relapsers Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Keith Alcorn / 08 December 2021 People who have experienced failure of multiple courses of direct-acting antiviral treatment can be cured of hepatitis C with a combination of three direct-acting antivirals plus ribavirin, a review of heavily treatment-experienced patients ... Advanced fibrosis in people with NAFLD increases the risk of liver complications Keith Alcorn / 08 December 2021 Advanced liver fibrosis in people with non-alcoholic fatty liver disease was associated with an increased risk of liver-related complications, a prospective study in the United States has found. Fat accumulation in the liver, ... Coronavirus COVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis Keith Alcorn / 22 November 2021 People with cirrhosis of the liver may take longer to achieve protection from SARS-CoV-2 and severe COVID-19 after vaccination, according to large studies in the United States and Chile, presented earlier this month ... Hepatitis C elimination Hepatitis C treatment in US declined from 2015 to 2020 Liz Highleyman / 14 November 2021 From a height of more than 164,000 in 2015, the number of people treated with direct-acting antiviral (DAA) therapy for hepatitis C has steadily declined, reaching a low point during the COVID-19 pandemic, ... Newsom signs bills to broaden STD testing, hepatitis screenings Bay Area Reporter / 25 October 2021 California Pioneers Mandatory Testing for Hepatitis B and C KQED / 25 October 2021 Treatment for people who use drugs Rapid hepatitis C treatment leads to high cure rate in young people who inject drugs Liz Highleyman / 12 October 2021 A simplified, same-day treatment model led to a higher cure rate compared with usual care for young people who inject drugs, according to research presented last week at the virtual IDWeek meeting. ... Treatment for people who use drugs Addressing the Intertwined Opioid, HIV, and HCV Crises: Q&A with Rick Altice Yale School of Medicine / 20 September 2021 ← First12345...56Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds